1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	26	26		-	-	9-11	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	diagnosticada	diagnosticar	VMP00SF	-	-	17-30	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	de	de	SPS00	C0332285	atributo	31-33	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	lupus	lupus	NCMS000	C0024141_1	trastorno_1	34-39	467_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
8	eritematoso	eritematoso		C0024141_2	trastorno_2	40-51	467_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	7	3734	Modif
9	sistémico	sistémico	NC00SC0	C0024141_3	trastorno_3	52-61	467_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	7	3734	Modif
10	,	,	Fc	-	-	61-62	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	en	en	SPS00	C1720294#C0332285	calificador#atributo	63-65	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	66-77	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	con	con	SPS00	C0332287	atributo	78-81	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	hidroxicloroquina	hidroxicloroquina	NCFS000	C0020336	producto#sustancia	82-99	467_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
15	,	,	Fc	-	-	99-100	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	que	que	PR0CN000	-	-	101-104	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	consulta	consultar	VMM02S0	C1704447_1	calificador_1	105-113	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	por	por	SPS00	C1704447_2	calificador_2	114-117	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	sensación	sensación	NCFS000	C0036658#C1455667	calificador	118-127	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	de	de	SPS00	C0332285	atributo	128-130	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
21	debilidad	debilidad	NCFS000	C0424594#C0004093#C3714552	hallazgo	131-140	467_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
22	generalizada	generalizar	VMP00SF	-	-	141-153	467_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	21	3734	Modif
23	que	que	PR0CN000	-	-	154-157	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
24	se	se	P00CN000	-	-	158-160	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
25	ha	haber	VAIP3S0	-	-	161-163	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
26	instaurado	instaurar	VMP00SM	-	-	164-174	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
27	progresivamente	progresivamente	RG	-	-	175-190	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
28	en	en	SPS00	C1720294#C0332285	calificador#atributo	191-193	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
29	los	el	DA0MP0	-	-	194-197	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
30	últimos	último	AO0MP0	-	-	198-205	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
31	15	15	Z	-	-	206-208	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
32	días	d	NCMP000	-	-	209-213	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
33	.	.	Fp	-	-	213-214	467_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	215-217	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	la	el	DA0FS0	-	-	218-220	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	221-232	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	233-239	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	se	se	P00CN000	-	-	240-242	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	aprecia	apreciar	VMIP3S0	-	-	243-250	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	palidez	palidez	NCFS000	C0030232#C1275397	hallazgo	251-258	467_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
8	cutánea	cutáneo	AQ0FS0	-	-	259-266	467_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	7	3735	LOC
9	y	y	CC	C1706368	calificador	267-268	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	en	en	SPS00	C1720294#C0332285	calificador#atributo	269-271	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	la	el	DA0FS0	-	-	272-274	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	analítica	analítica	NCFS000	-	-	275-284	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	destaca	destacar	VMIP3S0	-	-	285-292	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	Hb	hb	NC00YL0	-	-	293-295	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	7,4	7.4	Z	-	-	296-299	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	gr	g	NC00SC0	-	-	300-302	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	/	/	Fh	-	-	302-303	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	dL	decilitro	NCMN000	C0439241	calificador	303-305	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
19	,	,	Fc	-	-	305-306	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
20	Hcto	hematócrito	NC00YL0	-	-	307-311	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
21	31	31	Z	-	-	312-314	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
22	%	%	Ft	-	-	315-316	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
23	,	,	Fc	-	-	316-317	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
24	VCM	vcm	NC00SC0	C0524587	entidad_observable	317-320	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
25	108	108		-	-	321-324	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
26	.	.	Fp	-	-	324-325	467_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	¿	¿	Fia	-	-	326-327	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	327-331	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	332-334	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	las	el	DA0FP0	-	-	335-338	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	339-349	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	determinaciones	determinación	NCFP000	C0242485	procedimiento	350-365	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	será	ser	VSIF3S0	-	-	366-370	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	más	más	RG	C0205172	calificador	371-374	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	útil	útil	AQ0CS0	-	-	375-379	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	para	para	SPS00	C0521125	calificador	380-384	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	decidir	decidir	VMN0000	-	-	385-392	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	la	el	DA0FS0	-	-	393-395	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	actuación	actuación	NCFS000	C0699820	hallazgo	396-405	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	?	?	Fit	-	-	405-406	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	:	:	Fd	-	-	406-407	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	.	.	Fp	-	-	407-408	467_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

